These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28320852)

  • 1. Reprogramming Innate Immune Signaling in Cardiometabolic Disease.
    Zhang Y; Zhang XJ; Wang PX; Zhang P; Li H
    Hypertension; 2017 May; 69(5):747-760. PubMed ID: 28320852
    [No Abstract]   [Full Text] [Related]  

  • 2. The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
    Wang W; Zhang Y; Yang L; Li H
    Cancer Lett; 2017 Feb; 387():46-60. PubMed ID: 27339326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
    Cai J; Xu M; Zhang X; Li H
    Annu Rev Pathol; 2019 Jan; 14():153-184. PubMed ID: 30230967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.
    Xu M; Liu PP; Li H
    Physiol Rev; 2019 Jan; 99(1):893-948. PubMed ID: 30565509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
    Zhang Y; Li H
    Physiology (Bethesda); 2017 May; 32(3):210-223. PubMed ID: 28404737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trained Immunity and Cardiometabolic Disease: The Role of Bone Marrow.
    Mitroulis I; Hajishengallis G; Chavakis T
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):48-54. PubMed ID: 33207931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.
    Zhang Y; Zhang XJ; Li H
    Curr Drug Targets; 2017; 18(15):1754-1778. PubMed ID: 26240052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.
    Murphy AJ; Febbraio MA
    Nat Rev Immunol; 2021 Oct; 21(10):669-679. PubMed ID: 34285393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: A master regulator in macrophage and T cell immunity.
    Liu PS; Ho PC
    Mitochondrion; 2018 Jul; 41():45-50. PubMed ID: 29146487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune system regulation of nuclear hormone receptors in metabolic diseases.
    Chow EK; Razani B; Cheng G
    J Leukoc Biol; 2007 Aug; 82(2):187-95. PubMed ID: 17314330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases.
    Zauli G; Tisato V; Raffetto JD; Vaccarezza M
    Mediators Inflamm; 2017; 2017():3161968. PubMed ID: 28458468
    [No Abstract]   [Full Text] [Related]  

  • 12. C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
    Ridker PM; Bassuk SS; Toth PP
    Curr Atheroscler Rep; 2003 Sep; 5(5):341-9. PubMed ID: 12911843
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside.
    Zhang Y; Tan S; Xu J; Wang T
    Cell Physiol Biochem; 2018; 47(1):1-10. PubMed ID: 29763888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune signaling pathways in animals: beyond reductionism.
    Li X; Yu M; Zhu M
    Int Rev Immunol; 2009; 28(3-4):207-38. PubMed ID: 19811322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity and inflammation--New frontiers in comparative cardiovascular pathology.
    Linde A; Mosier D; Blecha F; Melgarejo T
    Cardiovasc Res; 2007 Jan; 73(1):26-36. PubMed ID: 17010957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressors of cytokine signaling and immunity.
    Kubo M; Hanada T; Yoshimura A
    Nat Immunol; 2003 Dec; 4(12):1169-76. PubMed ID: 14639467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage function and polarization in cardiovascular disease: a role of estrogen signaling?
    Bolego C; Cignarella A; Staels B; Chinetti-Gbaguidi G
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1127-34. PubMed ID: 23640494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome activation and metabolic disease progression.
    Li HB; Jin C; Chen Y; Flavell RA
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):699-706. PubMed ID: 25156419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARD9 signaling in the innate immune response.
    Ruland J
    Ann N Y Acad Sci; 2008 Nov; 1143():35-44. PubMed ID: 19076343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Cells.
    Sturtzel C
    Adv Exp Med Biol; 2017; 1003():71-91. PubMed ID: 28667554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.